GENEVA, Aug. 21 -- OSE IMMUNOTHERAPEUTICS filed a patent application (EP2026/053644) for “HUMANIZED ANTI-CLEC-1A ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF AND MIMETICS THEREOF”. With publication no. WO/2026/171766, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....